Mediclinic International PLC Completion of Successful Refinancing (5342C)
29 June 2016 - 12:45AM
UK Regulatory
TIDMMDC
RNS Number : 5342C
Mediclinic International PLC
28 June 2016
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
28 June 2016
Mediclinic International plc Completes Successful
Refinancing
Mediclinic International plc ("Mediclinic" or the "Company"), a
leading international private healthcare group, is pleased to
announce completion of the refinancing of the Mediclinic Bridge
Facility associated with the Company's combination with Al Noor
Hospitals Group plc.
Summary of new facilities:
-- South African senior bank loan totalling ZAR1.2 billion at an
interest rate of JIBAR +1.69% with a 3-year term expiring in June
2019
-- South African unsecured preference share funding totalling
ZAR1.5 billion at a rate of 73% of the prime overdraft interest
rate, with a 4-year term expiring in June 2020
-- United Arab Emirates bank loans of $54.5 million and $100.0
million at an interest rate of LIBOR + 2.75% with respective 4-year
and 5-year amortising terms, expiring in June 2020 and May 2021
The remainder of the GBP266 million drawn down from the
Mediclinic Bridge Facility has been satisfied by a $64.5 million
payment from existing cash resources.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information, please contact:
Company Secretary:
Victoria Dalby
Capita Company Secretarial Services Limited
+44 (0)207 954 9600
UK:
Liz Morley /Aarti Iyer/Lucy Stewart
Bell Pottinger
+44 (0)203 772 2468
South Africa:
Tertia Kruger
Mediclinic International
+27 21 809 6500
Notes:
Mediclinic is the world's third largest listed acute hospital
operator (outside of the United States), with three operating
platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing cost-effective
acute care specialised hospital services. The group operates 73
hospitals and 45 clinics.
Mediclinic also holds a 29.9% interest in Spire Healthcare, a
LSE-listed private healthcare group based in the UK.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBSGDLIDDBGLI
(END) Dow Jones Newswires
June 28, 2016 10:45 ET (14:45 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024